AIG (American International Group) — Execution Strategy #

Position Summary #

Pre-Buy Red Flag Check (executed 2026-04-07, same day as fill) #

shr-020 same-day check completed via stock-data-analyst agent. Verdict: PROCEED. Zero RED flags. Five AMBER items, all pre-existing in the Apr 3 thesis or sector-level noise:

• Price $75.97 (+0.7% vs $75.42 baseline) — well inside $72-$78 entry zone
• Q1 earnings confirmed for Apr 30, 2026 (AIG IR release Apr 6) — 23 days from execution, satisfies shr-034 30-day catalyst window
• Insider activity since Apr 3: only routine RSU awards (code A, Apr 1) and a Mar 3 CFO tax-withholding (code F, $80.49). No new open-market sells. CFO Walsh's Dec 30 buy at $86.54 remains the most recent open-market insider transaction.
• Analyst consensus improved: 9 Buy / 14 Hold / 0 Sell (was 8/14/0 at thesis date). Goldman upgrade (Mar 5, PT $90) live. Morgan Stanley trimmed PT $83→$82 on Apr 6 — sector-wide macro revision (also cut KNSL -22%, TWFG), still bullish, $6 above current price.
• Short interest unchanged: 2.14% / 2.09 days to cover.
• Sector AMBER: Q1 cat losses elevated (Winter Storm Fern $4-6.7B industry) but AIG's commercial/E&S skew limits exposure relative to personal-lines carriers. Tariff claims inflation 1-3pt CR pressure industry-wide.
• CEO Zaffino succession: Andersen as President effective Feb 16, 2026. Already known since Jan 6, 2026 — Apr 3 thesis was written with full awareness and still scored AIG #1/9. The plan's "CEO Zaffino departure → RE-SCORE" trigger is hereby logged as performed by the Apr 3 thesis. No further action.

Note for Apr 30 T2 decision: stock-data-analyst returned a Finnhub Q1 EPS consensus of $1.94, vs the $2.43 baseline used in this plan's T2 GO/NO-GO conditions. Re-verify the consensus number a few days before earnings so the T2 trigger is set against the right baseline.

T2 GO Decision (2026-04-30 → executed 2026-05-04) #

Q1 FY26 results released Apr 30. Street consensus at the time was $1.89 (not $2.43 — that figure was an internal projection, never published consensus). All four GO conditions cleanly met:

T2 deployed 4 trading days after earnings via limit order at $78.00. Slight delay (vs same-day) was acceptable — earnings beat held, no chase risk, fill just $1.85 above T1 price (+2.4%).

Pipeline Score #

Pre-Buy Red Flag Check (2026-04-03) #

GREEN (thesis intact — strong signals) #

• Earnings momentum: 4-for-4 quarterly beats in 2025. Average surprise +15.6%. Q3 beat by +28.5%. Full year 2025 adjusted ATIPS $7.09/share (+43% YoY) — first >$7 year in over a decade.
• Underwriting discipline: 17 consecutive quarters with combined ratio below 90%. Q4 2025: 88.8%. Full year accident year combined ratio: 88.3% (improved from 91.8%).
• Capital return: $10B buyback authorization — 25% of $40.7B market cap. Already returned $6.8B in 2025 ($5.8B buybacks + $1B dividends). Share count reduced from 606M to 538M (-11% in one year).
• Insider buying (shr-002): CFO Keith Walsh bought ~2,681 shares at $86.54 on Dec 30, 2025 ($232K personal money). Director John G. Rice bought 10,000 shares at $77.00 on Feb 13, 2025 ($770K). Director John C. Inglis made repeated small purchases throughout 2025 ($77-$86 range). These are independent officers spending their own money — the strongest bullish signal per the playbook.
• Analyst consensus: 8 Buy / 14 Hold / 0 Sell. Zero sells. Average PT $87.50 (+16%). Current price $75.42 is below every single analyst price target including the $79 low. KBW Outperform PT $97 (+29%).
• Balance sheet (shr-015 adjusted): Financial D/E only 0.22x (headline 24.4x includes policyholder liabilities — not financial distress). Interest coverage 10.8x. $41.1B equity. Net financial debt $7.9B.
• Short interest: 2.1% of float, 2.1 days to cover. Negligible — not a sentiment overhang.
• Corebridge divestiture: Remaining ~5% stake being wound down. $750M Corebridge buyback from AIG at $30.42 (Feb 2026). Simplification complete.
• Core Operating ROE: 11.1% — first time above 10% in over 10 years. Turnaround proof point.

AMBER (watch closely) #

• Catastrophe exposure: Currently favorable — 17 quarters below 90% combined ratio partly reflects benign cat years. Mean reversion is the primary risk. A 2017-style multi-peril year could push combined ratio to 95-100%+.
• Reserve adequacy / social inflation: Industry-wide $9B estimated reserve deficiency at year-end 2024. Social inflation (nuclear verdicts, litigation funding) inflating claim severity in long-tail casualty. AIG writes significant excess casualty, D&O, and general liability. If reserves prove deficient by 5-10%, that's a $1-2B+ pretax charge.
• Revenue trajectory: Revenue declined modestly 3 consecutive years ($29.98B → $26.77B). This is Corebridge separation shrinkage, not operational deterioration. Underwriting income is the correct metric, and it's growing rapidly.
• Officer selling cluster (May 2025): 5 officers sold $11.9M combined at $83-84 after options exercises. These were compensation-related (exercise + sell) at prices ~10% above current. Ambiguous but offset by CFO buy at $86.54.
• Investment portfolio: $83.4B in investments. Credit spread widening or rate volatility could hit AOCI. Negative $4.99B AOCI at year-end 2025 (recovering from -$7.1B in 2024).

RED (none currently) #

No RED flags identified. This is the only screen candidate where all major categories are GREEN or AMBER.

EXIT trigger check #

Entry Rationale #

AIG is a transformed global P&C insurer at the inflection point of a multi-year turnaround, trading at trough multiples (8.5x forward P/E) despite demonstrably improving fundamentals. The market still discounts AIG for its pre-2020 reputation as an undisciplined underwriter — a business that no longer exists.

The core thesis in three numbers:

1. 8.5x forward P/E on earnings that just grew 43% YoY
2. $10B buyback = 25% of market cap = ~15% EPS accretion over 2 years from buybacks alone
3. 0% implied growth at current price — the market prices zero growth for a company actively shrinking its share count by 11%/year

Graham IV sensitivity (per shr-012):

Break-even growth rate (trailing EPS): 2.7%. Even assuming zero organic growth, buyback-driven EPS accretion alone (~11%/yr share reduction) far exceeds the 2.7% needed to justify the price.

Why 2 tranches, not 1:

• T1 (60%) deploys now — the thesis is clear, shr-034 passes, and the April 30 earnings catalyst is within 30 days
• T2 (40%) deploys after April 30 Q1 2026 earnings — confirms the trajectory. If Q1 beats again, add regardless of price. If Q1 misses materially, re-evaluate.
• This mirrors shr-027: T1 before catalyst, T2 after data settles

Tranche Plan #

Tranche 1 — Deploy at Entry #

Tranche 2 — Post April 30 Q1 Earnings #

Exit Plan #

Profit targets (sell in thirds per shr-016) #

Fundamental stops (no price-based stop losses per shr-016/shr-024) #

Time horizon #

• Re-score after every quarterly earnings release (Q1 Apr 30, Q2 ~Jul, Q3 ~Oct, Q4 ~Feb)
• Exit if no progress by October 2027 (18 months)
• Hurricane season (Jun-Nov): Consider trimming 1/3 at TP1 ($87.50) pre-hurricane season if stock rallies. Cat risk is the primary downside scenario.

Klarman Downside Scenarios #

Expected value at $75.42: (0.50 x $93) + (0.25 x $62) + (0.10 x $40) + (0.15 x $60) = $46.50 + $15.50 + $4.00 + $9.00 = $75.00. At entry price, expected value is approximately breakeven on a 1-year horizon — but the 18-month buyback-driven EPS accretion (~15-20% cumulative) shifts the distribution materially higher. The thesis is that the buyback provides a structural margin of safety that the 1-year EV calculation understates.

Moat Assessment (Dorsey Framework) #

Verdict: Narrow moat. Sufficient to sustain above-cost-of-capital returns in a favorable pricing environment.

Context: Existing Portfolio Fit #

Diversification assessment: Adding AIG creates insurance sector concentration (AGN.AS + AIG = 2 insurers). However, the risk profiles are genuinely different:

• AGN: Life/retirement, interest rate sensitive, EU-regulated, share buyback driven
• AIG: P&C commercial, catastrophe sensitive, US-regulated, underwriting turnaround

The correlation is lower than it appears on sector labels. Both are capital-return stories, but the underlying risk drivers (rates vs. catastrophes vs. social inflation) are distinct. Acceptable.

Watchlist Alerts (to be set after T1 execution) #

Monitoring Calendar #

Key Data Points for Future Sessions #

These numbers are the baseline for re-scoring. A significant change in any signals a thesis change.

Related Files #

• Pipeline report: output/pipeline/reports/pipeline-2026-04-03.md
• Deep analysis scores: output/pipeline/deep-analysis/scores-2026-04-03.json
• Deep analysis narrative: output/pipeline/deep-analysis/phase2-2026-04-03.md
• Pipeline predictions: output/pipeline/predictions/predictions.json
• Composite screen: output/pipeline/screens/composite-2026-04-03.json